Dermtech Inc Asset Turnover Ratio (DMTK), as of first quarter 2024, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Dermtech Inc   (NASDAQ: DMTK)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare
 

Dermtech Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Dermtech Inc asset turnover ratio, the ability of Dermtech Inc 's assets to generate revenue in the first quarter 2024, increased sequentially to 0.09 in the first quarter (Mar 31 2024), DMTK's balance sheet remain strong.

Within sector 31 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the First Quarter 2024 compared to the preceding quarter from 3272 to 3276.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

DMTK Asset Turnover Ratio (Mar 31 2024)
I. Quarter		 (Dec 31 2023)
IV. Quarter		 (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter
Y / Y Asset Change -71.94 % 44.61 % -28.94 % -27.32 % -25.97 %
Y / Y Revenue Change 6.79 % 31.06 % -11.22 % -28.94 % -6.48 %
Asset Turnover Ratio (TTM) 0.09 0.07 0.08 0.07 0.07
DMTK's Total Ranking # 3276 # 3272 # 1280 # 3252 #
Seq. Asset Change -82.99 % 111.91 % -12.21 % -11.32 % -12.35 %
Seq. Revenue Change -5.38 % 23.71 % 5.45 % -13.49 % 16.13 %



Asset Turnover Ratio Company Ranking
Within: No.
Medical Laboratories Industry # 32
Healthcare Sector # 514
Overall Market # 3276

Asset Turnover Ratio Statistics
High Average Low
0.13 0.07 0.04
(Jun 30 2020)   (Dec 31 2021)




DMTK Company Profile • Back to DMTK Efficiency Comparisons • Compare DMTK Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Mar 31 2024, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Mar 31 2024 Assets at quarter ending Mar 31 2024
Strata Critical Medical Inc   0.76 $ 231.423  Millions$ 303.857  Millions
Palvella Therapeutics Inc   0.76 $ 40.927  Millions$ 53.774  Millions
Kaya Holdings Inc   0.76 $ 0.176  Millions$ 0.233  Millions
Tenet Healthcare Corp  0.75 $ 20,895.000  Millions$ 27,991.500  Millions
Tela Bio Inc   0.74 $ 61.634  Millions$ 82.897  Millions
Optinose Inc   0.74 $ 74.021  Millions$ 99.728  Millions
Nuwellis Inc   0.74 $ 8.014  Millions$ 10.854  Millions
Carlisle Companies Incorporated  0.74 $ 5,009.700  Millions$ 6,814.525  Millions
Bruker Corporation  0.73 $ 2,999.600  Millions$ 4,108.225  Millions
Apyx Medical Corp  0.73 $ 49.566  Millions$ 67.957  Millions
Nevro Corp   0.73 $ 430.261  Millions$ 590.716  Millions
Equillium Inc   0.73 $ 37.894  Millions$ 52.029  Millions
Penumbra Inc  0.73 $ 1,095.779  Millions$ 1,509.265  Millions
Enhabit Inc   0.73 $ 1,043.600  Millions$ 1,438.975  Millions
Scientific Industries Inc   0.73 $ 10.790  Millions$ 14.881  Millions
Cytosorbents Corporation  0.72 $ 36.266  Millions$ 50.088  Millions
Davita Inc   0.72 $ 12,338.003  Millions$ 17,053.025  Millions
Dr Reddy s Laboratories Limited  0.72 $ 3,350.000  Millions$ 4,650.000  Millions
Ati Physical Therapy Inc   0.72 $ 713.556  Millions$ 995.893  Millions
Paragon 28 inc   0.71 $ 223.639  Millions$ 312.811  Millions
Alphatec Holdings Inc   0.71 $ 511.444  Millions$ 719.561  Millions
Silk Road Medical Inc   0.71 $ 184.456  Millions$ 260.462  Millions
Insulet Corporation  0.71 $ 1,780.700  Millions$ 2,516.425  Millions
Intra cellular Therapies Inc   0.71 $ 513.930  Millions$ 726.649  Millions
Neuronetics Inc   0.70 $ 72.253  Millions$ 103.256  Millions
Biocryst Pharmaceuticals Inc   0.70 $ 355.395  Millions$ 509.415  Millions
Amneal Pharmaceuticals Inc   0.70 $ 2,495.439  Millions$ 3,579.233  Millions
Fortrea Holdings Inc   0.70 $ 3,006.900  Millions$ 4,317.575  Millions
Aytu Biopharma Inc  0.69 $ 91.645  Millions$ 132.366  Millions
Atricure Inc   0.69 $ 413.598  Millions$ 600.001  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.